Skip to main content
AbbVie8-K: Capex increase

AbbVie announces definitive agreement to acquire Apogee Therapeutics, Inc.

Source

SEC EDGARJun 22, 2026

Current report (Form 8-K)

AbbVie 8-K

Filing excerpt

On June 22, 2026, AbbVie Inc. (the “Company”) and Apogee Therapeutics, Inc. (“Apogee”) issued a joint press release announcing a definitive agreement pursuant to which the Company will acquire Apogee, on the terms and subject to the conditions set forth therein.

sec.gov/Archives/edgar/data/1551152/000110465926076067/tm2618365d1_8k...Read the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Capex increase

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Filed
Jun 22, 2026

The full record

From the Signal API record

Details

CIK
1551152
Accession number
0001104659-26-076067
Metric named
Value of definitive agreement to acquire Apogee Therapeutics, Inc.
Timeframe
Immediate
Filing year
2026
Why it matters
Budget available
Signal category
Financial

Extraction

Confidence
High
Relevance
90%
Sentiment
Neutral
Detected
Jun 23, 2026
signal_type
sec-8k
signal_subtype
capexIncrease

Use this data

Get every 8-K signal for AbbVie and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b23f3329-8e14-4437-95d1-7218aed87822 returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.

{
  "signal_id": "b23f3329-8e14-4437-95d1-7218aed87822",
  "signal_type": "sec-8k",
  "signal_subtype": "capexIncrease",
  "detected_at": "2026-06-23T07:10:48.181+00:00",
  "company": {
    "name": "AbbVie",
    "domain": "abbvie.com"
  },
  "data": {
    "detail": "This major acquisition represents a significant strategic investment, creating immediate needs for post-merger integration services across IT, finance, and HR systems. The complexity of combining two large organizations presents opportunities for vendors specializing in system consolidation and change management.",
    "metrics": {
      "timeframe": "immediate",
      "dollar_context": "Value of definitive agreement to acquire Apogee Therapeutics, Inc."
    },
    "summary": "AbbVie announces definitive agreement to acquire Apogee Therapeutics, Inc.",
    "excerpts": "On June 22, 2026, AbbVie Inc. (the “Company”) and Apogee Therapeutics, Inc. (“Apogee”) issued a joint press release announcing a definitive agreement pursuant to which the Company will acquire Apogee, on the terms and subject to the conditions set forth therein.",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465926076067/tm2618365d1_8k.htm",
    "filing_date": "2026-06-22",
    "filing_year": 2026,
    "sales_relevance": "Budget available",
    "signal_category": "financial"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.